David S. Rosenthal

3.0k total citations
56 papers, 2.2k citations indexed

About

David S. Rosenthal is a scholar working on Complementary and alternative medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, David S. Rosenthal has authored 56 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Complementary and alternative medicine, 17 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in David S. Rosenthal's work include Complementary and Alternative Medicine Studies (15 papers), Acupuncture Treatment Research Studies (15 papers) and Lymphoma Diagnosis and Treatment (12 papers). David S. Rosenthal is often cited by papers focused on Complementary and Alternative Medicine Studies (15 papers), Acupuncture Treatment Research Studies (15 papers) and Lymphoma Diagnosis and Treatment (12 papers). David S. Rosenthal collaborates with scholars based in United States, Australia and South Korea. David S. Rosenthal's co-authors include Weidong Lu, William C. Moloney, Elizabeth Dean‐Clower, Lee J. Levitt, David M. Dawson, Byeongsang Oh, Stephen Clarke, Nick Pavlakis, Phyllis Butow and Philip Beale and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David S. Rosenthal

56 papers receiving 2.1k citations

Peers

David S. Rosenthal
Jennifer S. Gewandter United States
John L. Faul United States
Marisa C. Weiss United States
Seong‐Kyu Kim South Korea
Richard Keen United Kingdom
David S. Rosenthal
Citations per year, relative to David S. Rosenthal David S. Rosenthal (= 1×) peers Fabien Despas

Countries citing papers authored by David S. Rosenthal

Since Specialization
Citations

This map shows the geographic impact of David S. Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Rosenthal more than expected).

Fields of papers citing papers by David S. Rosenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Rosenthal. The network helps show where David S. Rosenthal may publish in the future.

Co-authorship network of co-authors of David S. Rosenthal

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Rosenthal. A scholar is included among the top collaborators of David S. Rosenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Rosenthal. David S. Rosenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Weidong & David S. Rosenthal. (2018). Oncology Acupuncture for Chronic Pain in Cancer Survivors. Hematology/Oncology Clinics of North America. 32(3). 519–533. 25 indexed citations
2.
Lu, Weidong, et al.. (2014). Anticancer Effect of Fucoidan in Combination with Tyrosine Kinase Inhibitor Lapatinib. Evidence-based Complementary and Alternative Medicine. 2014(1). 865375–865375. 23 indexed citations
3.
Lu, Weidong & David S. Rosenthal. (2013). Acupuncture for Cancer Pain and Related Symptoms. Current Pain and Headache Reports. 17(3). 321–321. 62 indexed citations
4.
Lu, Weidong, Ursula A. Matulonis, Julie E. Dunn, et al.. (2012). The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial. Medical Acupuncture. 24(4). 233–240. 19 indexed citations
5.
Lu, Weidong, Peter M. Wayne, Roger B. Davis, et al.. (2012). Acupuncture for dysphagia after chemoradiation in head and neck cancer: Rationale and design of a randomized, sham-controlled trial. Contemporary Clinical Trials. 33(4). 700–711. 21 indexed citations
6.
Oh, Byeongsang, Phyllis Butow, Barbara Mullan, et al.. (2011). Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Supportive Care in Cancer. 20(6). 1235–1242. 159 indexed citations
7.
Oh, Byeongsang, Phyllis Butow, Barbara Mullan, et al.. (2010). The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific Journal of Clinical Oncology. 6(4). 342–349. 67 indexed citations
8.
Lu, Weidong & David S. Rosenthal. (2010). Recent Advances in Oncology Acupuncture and Safety Considerations in Practice. Current Treatment Options in Oncology. 11(3-4). 141–146. 49 indexed citations
9.
Lu, Weidong, Ursula A. Matulonis, Anne Doherty-Gilman, et al.. (2009). Acupuncture for Chemotherapy-Induced Neutropenia in Patients with Gynecologic Malignancies: A Pilot Randomized, Sham-Controlled Clinical Trial. The Journal of Alternative and Complementary Medicine. 15(7). 745–753. 45 indexed citations
10.
Oh, Byeongsang, Phyllis Butow, Barbara Mullan, et al.. (2009). Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Annals of Oncology. 21(3). 608–614. 167 indexed citations
11.
Butow, Phyllis, Barbara Mullan, Stephen Clarke, et al.. (2009). Randomized clinical trial of medical qigong on quality of life, fatigue, side effects, mood, status, and inflammation of cancer patients. Journal of Clinical Oncology. 27(15_suppl). 9617–9617. 3 indexed citations
12.
Lu, Weidong, Elizabeth Dean‐Clower, Anne Doherty-Gilman, & David S. Rosenthal. (2008). The Value of Acupuncture in Cancer Care. Hematology/Oncology Clinics of North America. 22(4). 631–648. 104 indexed citations
13.
Lu, Weidong, Elizabeth Dean‐Clower, Anne Doherty-Gilman, et al.. (2007). Acupuncture for Chemotherapy-Induced Leukopenia: Exploratory Meta-Analysis of Randomized Controlled Trials. PubMed. 5(1). 1–1. 42 indexed citations
14.
Rosenthal, David S. & Elizabeth Dean‐Clower. (2005). Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies. Hematology. 2005(1). 491–497. 36 indexed citations
15.
Tarbell, N J, Barbara Silver, C. Norman Coleman, et al.. (1993). Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 72(1). 207–212. 30 indexed citations
16.
Healey, Elizabeth, Nancy J. Tarbell, Leslie A. Kalish, et al.. (1993). Prognostic factors for patients with hodgkin disease in first relapse. Cancer. 71(8). 2613–2620. 41 indexed citations
17.
Gilliland, Gary, et al.. (1990). Multiple clones with (3;21) translocation in a case of Ph-positive chronic myelogenous leukemia during relapse after allogeneic bone marrow transplantation. Cancer Genetics and Cytogenetics. 47(1). 55–60. 10 indexed citations
18.
Druker, Brian, David S. Rosenthal, & G P Canellos. (1989). Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer. 63(6). 1060–1064. 13 indexed citations
19.
Whitmore, Willet F., Arthur T. Skarin, & David S. Rosenthal. (1982). Urological Presentations of Nonhodgkin’s Lymphomas. The Journal of Urology. 128(5). 953–956. 20 indexed citations
20.
Carabell, Steven C., John T. Chaffey, David S. Rosenthal, William C. Moloney, & Samuel Hellmän. (1979). Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas. Cancer. 43(3). 994–1000. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026